Interestingly, AKT and S6 phosphorylation were initially impaired after AZD8186 treatment in all investigated DLBCL cell lines, but recovered within 24 h only in the resistant DLBCL cell lines WSUDLCL2 and U2932 (Fig. 4a). The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.